Login / Signup

Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury.

Sheng-Nan CaoGuangjian HouYa MengYuan-Zhen ChenLiangyu XieBin Shi
Published in: Disease markers (2022)
Altogether, it identified the mechanisms by which AM&AS was used for SCI treatment, namely, active ingredients, targets and signaling pathways. Consequently, further research into AM&AS treating SCI can be conducted on this scientific basis.
Keyphrases
  • spinal cord injury
  • molecular docking
  • spinal cord
  • neuropathic pain
  • molecular dynamics simulations
  • signaling pathway
  • pi k akt
  • epithelial mesenchymal transition
  • human health
  • replacement therapy